We are live on ! Find out more
Barclays

Barclays Portfolio holdings

AUM $416B
1-Year Est. Return 33.63%
 

Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.

This Fund
S&P 500
This Quarter Est. Return
+8.84%
1 Year Est. Return
+33.63%
3 Year Est. Return
+104.86%
5 Year Est. Return
+133.18%
10 Year Est. Return
+529.74%
AUM
$212B
AUM Growth
+$25.4B
Cap. Flow
+$11.1B
Cap. Flow %
5.24%
Top 10 Hldgs %
35.63%
Holding
5,234
New
558
Increased
1,559
Reduced
2,300
Closed
327

Sector Composition

Rank Sector Weight
1 Technology 13.39%
2 Financials 7.95%
3 Communication Services 5.87%
4 Consumer Discretionary 5.85%
5 Healthcare 5.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GSEW icon
4626
Goldman Sachs Equal Weight US Large Cap Equity ETF
GSEW
$1.89B
$9K ﹤0.01%
+128
New +$8.38K
JOF
4627
Japan Smaller Capitalization Fund
JOF
$321M
$9K ﹤0.01%
1,000
MRKR icon
4628
Marker Therapeutics
MRKR
$18.8M
$9K ﹤0.01%
+339
New +$8.93K
PALL icon
4629
abrdn Physical Palladium Shares ETF
PALL
$618M
$9K ﹤0.01%
+175
New +$9.13K
PBPB
4630
DELISTED
Potbelly
PBPB
$9K ﹤0.01%
1,078
+677
+169% +$4.75K
STN icon
4631
Stantec
STN
$8.04B
$9K ﹤0.01%
211
-729
-78% -$32.9K
SUP
4632
DELISTED
Superior Industries International
SUP
$9K ﹤0.01%
1,088
-143
-12% -$982
ULBI icon
4633
Ultralife
ULBI
$86.4M
$9K ﹤0.01%
1,040
-6,557
-86% -$56.4K
RNTX
4634
Rein Therapeutics
RNTX
$63.1M
$9K ﹤0.01%
377
-205
-35% -$5.12K
TTOO
4635
DELISTED
T2 Biosystems, Inc
TTOO
$9K ﹤0.01%
2
-28
-93% -$181K
MARK
4636
DELISTED
Remark Holdings, Inc.
MARK
$9K ﹤0.01%
507
-10,249
-95% -$192K
AKU
4637
DELISTED
Akumin Inc
AKU
$9K ﹤0.01%
2,864
-3,249
-53% -$9.77K
BCSF icon
4638
Bain Capital Specialty
BCSF
$806M
$8K ﹤0.01%
508
+308
+154% +$4.86K
COPX icon
4639
Global X Copper Miners ETF NEW
COPX
$7.29B
$8K ﹤0.01%
+203
New +$8.02K
DBJP icon
4640
Xtrackers MSCI Japan Hedged Equity ETF
DBJP
$679M
$8K ﹤0.01%
+161
New +$7.92K
DRN icon
4641
Direxion Daily Real Estate Bull 3X ETF
DRN
$45.7M
$8K ﹤0.01%
353
+320
+970% +$6.33K
EMTY icon
4642
ProShares Decline of the Retail Store ETF
EMTY
$2.94M
$8K ﹤0.01%
250
FNX icon
4643
First Trust Mid Cap Core AlphaDEX Fund
FNX
$1.38B
$8K ﹤0.01%
+78
New +$7.65K
HDEF icon
4644
Xtrackers MSCI EAFE High Dividend Yield Equity ETF
HDEF
$2.34B
$8K ﹤0.01%
+337
New +$8.36K
SCJ icon
4645
iShares MSCI Japan Small-Cap ETF
SCJ
$253M
$8K ﹤0.01%
+99
New +$8.03K
SIEB icon
4646
Siebert Financial
SIEB
$66.7M
$8K ﹤0.01%
1,596
-8,067
-83% -$33.4K
SLNO
4647
DELISTED
Soleno Therapeutics
SLNO
$8K ﹤0.01%
439
-2,881
-87% -$48.7K
TIGO icon
4648
Millicom
TIGO
$16B
$8K ﹤0.01%
193
+100
+108% +$4.16K
TLTE icon
4649
FlexShares Morningstar Emerging Markets Factor Tilt Index Fund
TLTE
$336M
$8K ﹤0.01%
+117
New +$7.49K
WLKP icon
4650
Westlake Chemical Partners
WLKP
$763M
$8K ﹤0.01%
+300
New +$7.97K

Similar funds

Barclays's Q2 2021 Portfolio in Review

As of Q2 2021, Barclays held 5,234 positions worth $212B, up 14% from $186B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Barclays deployed $11.1B of net new capital in Q2 2021, opening 558 new positions and adding to 1,559 existing holdings. Its largest new stake was Proofpoint, Inc.: 1,241,690 shares worth $216M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 13% a quarter earlier, followed by Financials and Communication Services.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.14B trimmed.

  • Barclays's largest Q2 2021 buy was Proofpoint, Inc.: 1,241,690 shares worth $216M.
  • Barclays added most to iShares US Real Estate ETF in Q2 2021, an estimated $1.48B increase.
  • Barclays's biggest Q2 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.14B.
  • Barclays fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $466M.
  • Barclays's ten largest holdings make up 36% of its $212B portfolio in Q2 2021.
  • Barclays opened 558 new positions and closed 327 in Q2 2021.
  • Barclays's portfolio value rose 14% quarter-over-quarter to $212B.

Based on Barclays's 13F filing for Q2 2021, filed 13 Aug 2021.